Nicotinamide Mononucleotide (NMN), Global Market Size Forecast, Top 9 Players Rank and Market Share (Business Opportunities - Money Making)
AUNetAds > Business Opportunities > Money Making
Item ID 2382795 in Category: Business Opportunities - Money Making
Nicotinamide Mononucleotide (NMN), Global Market Size Forecast, Top 9 Players Rank and Market Share | |
Nicotinamide Mononucleotide (NMN) Market Summary Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately. According to the new market research report “Global Nicotinamide Mononucleotide (NMN) Market Report 2023-2029”, published by QYResearch, the global Nicotinamide Mononucleotide (NMN) market size is projected to reach USD 0.71 billion by 2029, at a CAGR of 12.6% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax, Genex Formulas, etc. In 2022, the global top four players had a share approximately 85.0% in terms of revenue.  | |
| Target State: All States Target City : All Cities Last Update : 21 March 2024 6:52 PM Number of Views: 94 | Item Owner : Jennifer Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |
AUNetAds > Business Opportunities > Money Making
© 2024 AUNetAds.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com | USAOnlineClassifieds.com
2024-12-27 (0.224 sec)